160 related articles for article (PubMed ID: 34494503)
1.
Kawabata M; Inoue N; Watanabe M; Kobayashi A; Hidaka Y; Miyauchi A; Iwatani Y
Autoimmunity; 2021 Nov; 54(7):450-459. PubMed ID: 34494503
[TBL] [Abstract][Full Text] [Related]
2. Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves' Disease and Hashimoto's Thyroiditis in Korean Patients.
Yoon JH; Shin MH; Kim HN; Choi W; Park JY; Hong AR; Kim HK; Kang HC
Endocrinol Metab (Seoul); 2021 Jun; 36(3):599-606. PubMed ID: 34074094
[TBL] [Abstract][Full Text] [Related]
3. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
[TBL] [Abstract][Full Text] [Related]
4. The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody.
Tomari S; Watanabe M; Inoue N; Mizuma T; Yamanaka C; Hidaka Y; Iwatani Y
Endocr J; 2017 Oct; 64(10):1025-1032. PubMed ID: 28845025
[TBL] [Abstract][Full Text] [Related]
5. Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease.
Mizuma T; Watanabe M; Inoue N; Arakawa Y; Tomari S; Hidaka Y; Iwatani Y
Autoimmunity; 2017 Sep; 50(6):386-392. PubMed ID: 28675712
[TBL] [Abstract][Full Text] [Related]
6. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases.
Saeki M; Watanabe M; Inoue N; Tokiyoshi E; Takuse Y; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Dec; 49(8):514-522. PubMed ID: 27808570
[TBL] [Abstract][Full Text] [Related]
7. Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases.
Akahane M; Watanabe M; Inoue N; Miyahara Y; Arakawa Y; Inoue Y; Katsumata Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Aug; 49(5):312-9. PubMed ID: 27245471
[TBL] [Abstract][Full Text] [Related]
8. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
[TBL] [Abstract][Full Text] [Related]
9. Methylation levels of the TNFA gene are different between Graves' and Hashimoto's diseases and influenced by the TNFA polymorphism.
Morita E; Watanabe M; Inoue N; Hashimoto H; Haga E; Hidaka Y; Iwatani Y
Autoimmunity; 2018 May; 51(3):118-125. PubMed ID: 29526119
[TBL] [Abstract][Full Text] [Related]
10. Functional Polymorphisms of the Type 1 and Type 2 Iodothyronine Deiodinase Genes in Autoimmune Thyroid Diseases.
Inoue N; Watanabe M; Katsumata Y; Ishido N; Hidaka Y; Iwatani Y
Immunol Invest; 2018 Jul; 47(5):534-542. PubMed ID: 29648895
[TBL] [Abstract][Full Text] [Related]
11. Association between functional SIRT1 polymorphisms and the clinical characteristics of patients with autoimmune thyroid disease.
Sarumaru M; Watanabe M; Inoue N; Hisamoto Y; Morita E; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Aug; 49(5):329-37. PubMed ID: 27245255
[TBL] [Abstract][Full Text] [Related]
12. Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody.
Inoue N; Watanabe M; Nanba T; Wada M; Akamizu T; Iwatani Y
Clin Exp Immunol; 2009 May; 156(2):199-204. PubMed ID: 19250279
[TBL] [Abstract][Full Text] [Related]
13. Association of
Yamamoto M; Watanabe M; Inoue N; Watanabe A; Ozaki H; Ohsaki M; Hidaka Y; Iwatani Y
Immunol Invest; 2020 Feb; 49(1-2):106-119. PubMed ID: 31505972
[TBL] [Abstract][Full Text] [Related]
14. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.
Inoue N; Watanabe M; Ishido N; Katsumata Y; Kagawa T; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):262-9. PubMed ID: 25046415
[TBL] [Abstract][Full Text] [Related]
15. Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases.
Inoue N; Watanabe M; Morita M; Tatusmi K; Hidaka Y; Akamizu T; Iwatani Y
Clin Exp Immunol; 2011 Mar; 163(3):318-23. PubMed ID: 21235536
[TBL] [Abstract][Full Text] [Related]
16. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.
Inoue N; Watanabe M; Yamada H; Takemura K; Hayashi F; Yamakawa N; Akahane M; Shimizuishi Y; Hidaka Y; Iwatani Y
J Clin Immunol; 2012 Dec; 32(6):1243-52. PubMed ID: 22706687
[TBL] [Abstract][Full Text] [Related]
17. The IL15 +96522 A>T functional polymorphism is related to the differentiation of Th17 cells and the severity of Hashimoto's disease.
Arakawa Y; Watanabe M; Takemura K; Inoue N; Hidaka Y; Iwatani Y
Int J Immunogenet; 2017 Apr; 44(2):41-50. PubMed ID: 28164472
[TBL] [Abstract][Full Text] [Related]
18. Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases.
Inoue Y; Watanabe M; Inoue N; Kagawa T; Shibutani S; Otsu H; Saeki M; Takuse Y; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):229-35. PubMed ID: 24990808
[TBL] [Abstract][Full Text] [Related]
19. Association of B7H3 and B7H4 gene polymorphisms and protein expression with the development and prognosis of autoimmune thyroid diseases.
Ozaki H; Inoue N; Iwatani Y; Watanabe A; Yamamoto M; Kitahara N; Tanikawa S; Noguchi Y; Hidaka Y; Watanabe M
Clin Endocrinol (Oxf); 2023 Jul; 99(1):103-112. PubMed ID: 37066992
[TBL] [Abstract][Full Text] [Related]
20. Increases of CD80 and CD86 Expression on Peripheral Blood Cells and their Gene Polymorphisms in Autoimmune Thyroid Disease.
Watanabe A; Inoue N; Watanabe M; Yamamoto M; Ozaki H; Hidaka Y; Iwatani Y
Immunol Invest; 2020 Feb; 49(1-2):191-203. PubMed ID: 31755324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
